title: 18 F-click labeling and preclinical evaluation of a new 18 F-folate for PET imaging.
abstract: BACKGROUND
  The folate receptor (FR) is a well-established target for tumor imaging and therapy. To date, only a few 18 F-folate conjugates via 18 F-prosthetic group labeling for positron emission tomography (PET) imaging have been developed. To some extent, they all lack the optimal balance between efficient radiochemistry and favorable in vivo characteristics.
  
  
  METHODS
  A new clickable olate precursor was synthesized by regioselective coupling of folic acid to 11-azido-3,6,9-trioxaundecan-1-amine at the γ-position of the glutamic acid residue. The non-radioactive reference compound was synthesized via copper-catalyzed azide-alkyne cycloaddition of 3-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)prop-1-yne and γ-(11-azido-3,6,9-trioxaundecanyl)folic acid amide. The radiosynthesis was accomplished in two steps: at first a 18 F-fluorination of 2-(2-(2-(prop-2-yn-1-yloxy)ethoxy)ethoxy)ethyl-4-methylbenzenesulfonate, followed by a 18 F-click reaction with the γ-azido folate. The in vitro, ex vivo, and in vivo behaviors of the new 18 F-folate were investigated using FR-positive human KB cells in displacement assays and microPET studies using KB tumor-bearing mice.
  
  
  RESULTS
  The new 18 F-folate with oligoethylene spacers showed reduced lipophilicity in respect to the previously developed 18 F-click folate with alkyl spacers and excellent affinity (Ki = 1.6 nM) to the FR. Combining the highly efficient 18 F-click chemistry and a polar oligoethylene-based 18 F-prosthetic group facilitated these results. The overall radiochemical yield of the isolated and formulated product averages 8.7%. In vivo PET imaging in KB tumor-bearing mice showed a tumor uptake of 3.4% ID/g tissue, which could be reduced by FR blockade with native folic acid. Although the new 18 F-oligoethyleneglycole (OEG)-folate showed reduced hepatobiliary excretion over time, a distinct unspecific abdominal background was still observed.
  
  
  CONCLUSIONS
  A new 18 F-folate was developed, being available in very high radiochemical yields via a fast and convenient two-step radiosynthesis. The new 18 F-OEG-folate showed good in vivo behavior and lines up with several recently evaluated 18 F-labeled folates.
authors.affiliation: Institute of Nuclear Chemistry, Johannes Gutenberg University Mainz, Mainz 55128, Germany. schiefe@uni-mainz.de.
authors.forename: Hanno
authors.initials: H
authors.lastname: Schieferstein
authors.forename: Thomas
authors.initials: T
authors.lastname: Betzel
authors.forename: Cindy R
authors.initials: CR
authors.lastname: Fischer
authors.forename: Tobias L
authors.initials: TL
authors.lastname: Ross
references.citation: Bioconjug Chem. 2008 Dec;19(12):2462-70
references.pmid: 19053298
references.citation: Annu Rev Nutr. 1996;16:501-21
references.pmid: 8839936
references.citation: Bioconjug Chem. 2007 Nov-Dec;18(6):1987-94
references.pmid: 18030991
references.citation: Acc Chem Res. 2008 Jan;41(1):120-9
references.pmid: 17655275
references.citation: J Nucl Med. 2006 Jul;47(7):1153-60
references.pmid: 16818950
references.citation: Med Lab Sci. 1981 Jul;38(3):187-95
references.pmid: 7334916
references.citation: Cancer Res. 1992 Jun 15;52(12):3396-401
references.pmid: 1596899
references.citation: Bioconjug Chem. 1996 Jan-Feb;7(1):56-62
references.pmid: 8741991
references.citation: Nucl Med Biol. 2012 Aug;39(6):864-70
references.pmid: 22445744
references.citation: J Biol Chem. 1979 Nov 25;254(22):11312-8
references.pmid: 500647
references.citation: J Nucl Med. 2010 Nov;51(11):1756-62
references.pmid: 20956469
references.citation: Biochem Pharmacol. 1973 Dec 1;22(23):3099-108
references.pmid: 4202581
references.citation: Nucl Med Biol. 2011 Jul;38(5):715-23
references.pmid: 21718947
references.citation: Nucl Med Biol. 2007 Aug;34(6):603-8
references.pmid: 17707799
references.citation: Curr Pharm Des. 2012;18(8):1058-83
references.pmid: 22272825
references.citation: Clin Pharmacokinet. 2001;40(7):539-51
references.pmid: 11510630
references.citation: Eur J Nucl Med Mol Imaging. 2004 Jan;31(1):117-28
references.pmid: 14523586
references.citation: Arthritis Res Ther. 2013 Mar 01;15(2):R37
references.pmid: 23452511
references.citation: J Biol Chem. 1985 Dec 5;260(28):14911-7
references.pmid: 4066659
references.citation: Bioconjug Chem. 2013 Feb 20;24(2):205-14
references.pmid: 23273015
references.citation: Proc Natl Acad Sci U S A. 1986 Aug;83(16):5983-7
references.pmid: 3461471
references.citation: Bioconjug Chem. 2012 Apr 18;23(4):805-13
references.pmid: 22372827
references.citation: Drug Discov Today. 2001 Jan 1;6(1):44-51
references.pmid: 11165172
references.citation: J Nucl Med. 1998 Sep;39(9):1579-85
references.pmid: 9744347
references.citation: Anal Biochem. 2005 Mar 15;338(2):284-93
references.pmid: 15745749
references.citation: Nucl Med Biol. 2003 Oct;30(7):725-31
references.pmid: 14499330
references.citation: Bioconjug Chem. 2008 Aug;19(8):1689-95
references.pmid: 18646835
references.citation: J Med Chem. 2010 Oct 14;53(19):6811-24
references.pmid: 20666486